Author(s): Avinash S. Khairnar, Mangesh S. Bhalerao, Pravin M. Bolshete

Email(s): avinashkhairnar@gmail.com

DOI: Not Available

Address: Avinash S. Khairnar*, Mangesh S. Bhalerao and Pravin M. Bolshete
University Department of Interpathy Research and Technology, Maharashtra University of Health Science, Nashik (MS) 420 004
*Corresponding Author

Published In:   Volume - 4,      Issue - 8,     Year - 2011


ABSTRACT:
Background: Burn injuries are common in India. The medical community should take steps to improve the rational use of drugs in burn population. Objective: To determine the Drug Utilization (DU) 90% pattern in burn population. Materials and Methods: A prospective cross-sectional study was conducted in burn ward, tertiary health care centre, Nashik in patients aged between 18-60 years and burn percentage >15%. Prescriptions were copied from the day of admission till discharge, death or non compliance of patients. DU 90%, core indicators and Defined Daily Dosage (DDD) were calculated. Result: Average percentage of burn was 61.96%. 31 patients died (62%) and 19 were survived (38%). Mortality rate was 20% in < 40% Total Body Surface Area (TBSA), 33% in 40-60% TBSA, 95% in TBSA >60%. Drug used in percentage was higher for Ringer Lactate (21.57%), Inj. Gentamicin (8.52%), Inj. Rinitidine (8.38%), Inj. Metronidazole (8.25%), Inj. Cefoperazone + Sulbactum (8.24%) and Inj. Ciprofloxacin (5.58%). The DDD% was found highest for Inj. Dexamethasone (23.3%) and lowest for Inj. Cefoperazone + Sulbactum (0.75%). DU 90% includes Inj. Dexamethasone (23.3%), Inj. Adrenaline (15.85%), Inj. Hydrocortisone (14.35%), Tab. Ranitidine (8.41%), Inj. Diclofenac (3.84%), Tab. Folic Acid (3.76%), Inj. Deriphyllin (3.52%), Tab. Diclofenac (3.5%), Inj. Sulbactum (3.01%), Tab. Ciprofloxacin (3%), Tab. Calcium Citrate (2.44%), Inj. Ciprofloxacin (2.32%), Tab. Ferrous Sulphate (2.2%), Inj. Metronidazole (2.16%), Inj.Gentamicin (1.96%). Conclusion: Based on the observations made in this preliminary study (DU90%), there is need of multicentric (including private hospitals) and long duration evaluation with consideration of age, sex, socioeconomic factors to estimate the rational DU pattern in burn population.


Cite this article:
Avinash S. Khairnar, Mangesh S. Bhalerao, Pravin M. Bolshete. Drug Utilization (DU) 90% Study in Burn Population. Research J. Pharm. and Tech. 4(8): August 2011; Page 1246-1249.

Cite(Electronic):
Avinash S. Khairnar, Mangesh S. Bhalerao, Pravin M. Bolshete. Drug Utilization (DU) 90% Study in Burn Population. Research J. Pharm. and Tech. 4(8): August 2011; Page 1246-1249.   Available on: https://rjptonline.org/AbstractView.aspx?PID=2011-4-8-9


Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

0.38
2018CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available